Adherence to minimal retesting interval for HbA1c, vitamin D and thyrotropin in the University Hospital of Nepal.

IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL
SAGE Open Medicine Pub Date : 2025-02-23 eCollection Date: 2025-01-01 DOI:10.1177/20503121251321668
Saroj Thapa, Meera Hada, Bhushan Tusuju, Apeksha Niraula
{"title":"Adherence to minimal retesting interval for HbA1c, vitamin D and thyrotropin in the University Hospital of Nepal.","authors":"Saroj Thapa, Meera Hada, Bhushan Tusuju, Apeksha Niraula","doi":"10.1177/20503121251321668","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Laboratory testing plays a critical role in healthcare decision-making; however, concerns regarding overutilization and inappropriate testing persist. Minimum retesting intervals serve as a tool to optimize testing practices and resource allocation. This study aimed to assess adherence to minimum retesting interval guidelines and estimate associated costs for commonly prescribed tests, namely HbA1c, 25 hydroxyvitamin D (Vitamin D), and thyrotropin, in a university hospital setting in Nepal.</p><p><strong>Methods: </strong>This observational study utilized secondary data from medical records covering 1 year. Adherence to minimum retesting interval guidelines was evaluated based on established recommendations, and the economic burden of inappropriate testing was estimated using cost data provided by the Health Insurance Board of Nepal.</p><p><strong>Results: </strong>Patients who underwent TSH, HbA1c, and Vitamin D testing during the study period were 27,960, 8558, and 5416 with the total number of tests being 38,718 TSH, 13,859 HbA1c, and 5977 Vitamin D, respectively. There were notable proportions of patients with minimum retesting interval breach, that is, <i>n</i> = 1317 for thyroid stimulating hormone (4.71%), <i>n</i> = 1159 for HbA1c (13.54%) and <i>n</i> = 232 for Vitamin D (4.28%). Minimum retesting interval breaches were identified across all parameters, with associated costs of $12,817 which could be saved if there were no minimum retesting interval breaches. Variations in minimum retesting interval adherence were observed between insured and noninsured patients and among tests falling within and outside reference ranges.</p><p><strong>Conclusion: </strong>The findings highlight the prevalence of minimum retesting interval breaches and inappropriate testing practices, emphasizing the need for interventions to optimize laboratory testing utilization. Addressing these challenges through context-specific strategies can enhance resource allocation and patient care while mitigating financial burdens.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251321668"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11848881/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SAGE Open Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20503121251321668","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Laboratory testing plays a critical role in healthcare decision-making; however, concerns regarding overutilization and inappropriate testing persist. Minimum retesting intervals serve as a tool to optimize testing practices and resource allocation. This study aimed to assess adherence to minimum retesting interval guidelines and estimate associated costs for commonly prescribed tests, namely HbA1c, 25 hydroxyvitamin D (Vitamin D), and thyrotropin, in a university hospital setting in Nepal.

Methods: This observational study utilized secondary data from medical records covering 1 year. Adherence to minimum retesting interval guidelines was evaluated based on established recommendations, and the economic burden of inappropriate testing was estimated using cost data provided by the Health Insurance Board of Nepal.

Results: Patients who underwent TSH, HbA1c, and Vitamin D testing during the study period were 27,960, 8558, and 5416 with the total number of tests being 38,718 TSH, 13,859 HbA1c, and 5977 Vitamin D, respectively. There were notable proportions of patients with minimum retesting interval breach, that is, n = 1317 for thyroid stimulating hormone (4.71%), n = 1159 for HbA1c (13.54%) and n = 232 for Vitamin D (4.28%). Minimum retesting interval breaches were identified across all parameters, with associated costs of $12,817 which could be saved if there were no minimum retesting interval breaches. Variations in minimum retesting interval adherence were observed between insured and noninsured patients and among tests falling within and outside reference ranges.

Conclusion: The findings highlight the prevalence of minimum retesting interval breaches and inappropriate testing practices, emphasizing the need for interventions to optimize laboratory testing utilization. Addressing these challenges through context-specific strategies can enhance resource allocation and patient care while mitigating financial burdens.

尼泊尔大学医院对HbA1c、维生素D和促甲状腺激素最小复检间隔的依从性
背景:实验室检测在医疗保健决策中起着关键作用;然而,关于过度使用和不适当测试的担忧仍然存在。最小的重新测试间隔可以作为优化测试实践和资源分配的工具。本研究旨在评估尼泊尔一所大学医院对最低复检间隔指南的依从性,并估计常用的处方检查(即HbA1c、25羟维生素D(维生素D)和促甲状腺激素)的相关成本。方法:本观察性研究利用了1年医疗记录的二手数据。根据既定建议评估了对最低重新检测间隔准则的遵守情况,并利用尼泊尔健康保险局提供的费用数据估计了不适当检测的经济负担。结果:在研究期间,接受TSH、HbA1c和维生素D检测的患者分别为27,960、8558和5416例,TSH、HbA1c和维生素D检测总数分别为38,718例、13,859例和5977例。最小重测间隔突破的患者比例显著,促甲状腺激素为1317例(4.71%),糖化血红蛋白为1159例(13.54%),维生素D为232例(4.28%)。在所有参数中确定了最小重新测试间隔违规,相关成本为12,817美元,如果没有最小重新测试间隔违规,则可以节省成本。在有保险和没有保险的患者之间,以及在参考范围内和之外的测试之间,观察到最小重新测试间隔依从性的差异。结论:研究结果强调了最小复检间隔违规和不适当的检测实践的普遍存在,强调了干预措施优化实验室检测利用的必要性。通过针对具体情况的战略应对这些挑战,可以加强资源分配和患者护理,同时减轻财政负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
SAGE Open Medicine
SAGE Open Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
3.50
自引率
4.30%
发文量
289
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信